Published in Diabetes Week, February 12th, 2007
If successful, the trial could lead one day to an inexpensive way to treat this most common form of diabetes, which has been increasing at epidemic rates in recent years.
About 800 adults with poorly controlled blood glucose levels are being sought to participate in the 3-year study, referred to as Targeting Inflammation...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.